Biotechnology in Belgium

Agri-Osmoz

BiosmoZ vous présente la première gamme 100% naturelle pour la culture biologique comprenant, BiosmoZ le seul amendement hydro-rétenteur et électro-conducteur + naturel au monde, BactosmoZ une préparation bactérienne de dernière génération et MycosmoZ un mélange de mycorhizes et bactéries. Vos plantes vont adorer! 1) BiosmoZ: Un amendement hydro-rétenteur ionique +: Il capte l'eau et les nutriments et les rend instantanément à la demande de la plante. Sa structure permet aux bactéries d'y nicher, créant ainsi des milliers de bio-réacteurs. 2) BactosmoZ: Une préparation bactérienne de dernière génération: Les bactéries accélèrent la minéralisation des nutriments & augmentent l'accès à l'Azote. 3) MycosmoZ: Un mélange mycorhizes et bactéries: Les mycorhizes colonisent les racines et augmentent la capacité d'absorption des nutriments dont le Phosphore.

1 to 10 staff

Equaly Sa

Equaly is a discovery-stage biotechnology company, dedicated to leverage the role of a newly discovered type of Natural Killer T (“NKT”) cells to propose an innovative immunological approach to fight and eliminate tumour cells. Based on a newly discovered population of NKT lymphocytes, that can be activated by specific antigen through the same mechanism for everyone, allowing allogenic applications, Equaly develops innovative therapies that have the potential to revolutionise the treatment of cancers by offering a safer, more effective, and more affordable option than current therapies. Using the dynamic of the very same NKT cells, Equaly also develops non-immunogenic versions of existing Enzyme Replacement Therapies against metabolic orphan diseases.

1 to 10 staff

Harmony Clinical Research Bv

11 to 50 staff

Turnstone Communications

Turnstone Communications, part of the QbD Group, offers communications and business development services to the life sciences and pharma sector. Our team all have a background in life science research and know the challenge of turning innovation into excitement. This makes for efficient collaboration and quick results. We have the skills to translate your content into an effective message that resonates with clients, partners, and investors alike. BioVox is a news platform supported by Turnstone, which shares insights from the Belgian life sciences ecosystem with a global community of readers.

1 to 10 staff

The Proteinn Club

The ProteInn Club facilitates innovations and accelerates the further development of a really unique fermentation-based protein ecosystem. We bring together all actors to contribute to a more sustainable food system and circular bio-economy.

1 to 10 staff

Realco

Without efficient cleaning, disinfection is an illusion. Having pioneered the development of enzyme-based cleaning, Realco makes perfect hygiene a reality. Thanks to our proven expertise in enzymes, Realco is able to offer highly efficient cleaning solutions. Realco offers hygiene solutions to both professionals and consumers, enabling: 1) the food and beverage industry to - ensure food quality and safety - extend the shelf-life of produce 2) the institutional and private catering sectors to - decrease the risk of food contamination - ensure employees' safety (via pH neutral cleaning products) 3) the hospitals to reduce the risk of hospital-acquired infections 4) the consumers to favour thorough daily cleaning vs. disinfection (as too much disinfection weakens the immune defense system) For more information check out our website :

51 to 200 staff

Remynd

Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Huntington’s disease. By targeting the underlying disease mechanisms, reMYND aims to restore neuronal function and slow disease progression. With a strong commitment to innovation and patient impact, the company advances breakthrough therapies from discovery to clinical development.

11 to 50 staff

Confo Therapeutics

Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium. For more information:

51 to 200 staff

Exothera

Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660

201 to 500 staff

Alco Bio Fuel Nv

Alco Bio Fuel NV is a young biorefinery that was started in 2008 in Ghent. It is the largest producers of bioethanol, animal feed and CO₂ in Belgium. The Ghent factory is part of the Alcogroup, one of the largest bioethanol producer in Europe, and Vanden Avenne, a specialized grain trader. As Alco Bio Fuel Ghent, we are a sustainable organization that have as a goal to be climate-neutral by 2030. The factory in Ghent has approximately 50 employees. Alco Bio Fuel Ghent makes a solid contribution to sustainably energy use in transport.

11 to 50 staff

Mrm Health

MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition Biosciences in the development of microbiome-based therapeutics for metabolic diseases. MRM Health's proprietary technology platform brings live microbial therapeutics development to the next level by combining rationally selected strains into synergistic consortia through a proprietary optimization process.

11 to 50 staff

Biorics

BioRICS’ mission is to improve the overall well-being and the mental and physical fitness of individuals. BioRICS offers wearable monitoring systems with dedicated analysing software to deliver biofeedback on the individual's status and performance. Being a spin-off of KU Leuven, BioRICS uses" individual-centric" algorithmic models based on scientific knowledge and experience. The BioRICS monitoring systems are applicable in many fields such as sports (physical monitoring), fitness & well-being (physical and mental monitoring), in work environment (stress monitoring), in traffic (drowsiness monitoring), etc. In a nutshell, BioRICS supports people to connect with their body and learn what the body already knew!

1 to 10 staff

Etherna

Driving discovery and solving challenges for partners across LNP formulation and RNA chemistry | We are an RNA technology company, with over 30 years of experience, offering professional partnership to pharma and biotech with an emerging or established interest in RNA therapeutics. Our expert team supports start-up, early-stage, and late-stage projects by using our proprietary platforms across RNA chemistry, LNP formulation, and Process Technology, to drive new pipeline development or resolve manufacturing challenges for our partners.

51 to 200 staff

Isala

Meet Isala, our ambitious citizen science project at the University of Antwerp. In March 2020, we launched a call to find 200 women in Belgium willing to take simple swab samples from their vaginas, skin, and saliva to analyze the female microbiome. The microbiome describes all bacteria living on and in an individual that contributes to health and well being. We were looking for 200 women and found more than enthusiastic volunteers! Our first results point to fascinating results linking bacteria to the lifestyle and health of the volunteering women. We are expanding our activities, and Isala is now becoming a highly ambitious international program dedicated to breaking taboos, informing the general public on women’s health, and building a vibrant community to support equal rights for women and inclusivity. Isala’s driving force is Prof. Sarah Lebeer’s research group, a team of dedicated scientists fascinated by bacteria and their positive influence on our health. The multidisciplinary team includes microbiologists, bioinformaticians, and bioengineers collaborating with multiple parties, such as gynecologists and general practitioners, to better understand how we live with our bacteria. For more information, visit https://lebeerlab.com/."Every step we can take with Isala is a step towards more knowledge, more understanding and more attention to female health. And we are very happy that such a wonderful, enthusiastic community is walking with us. Thank you!"~ the Isala research team

11 to 50 staff

Bipp

We are a buyer-driven SaaS procurement solution designed for academia, startups, and SMEs in Life Sciences, Biotech, and Healthcare. By focusing on functionality, cost efficiency, and human relationships, BIPP streamlines procurement, ensures compliance, and provides cost-saving opportunities—all while maintaining a strong customer-first approach. BIPP hosts over 17 simulaneously searchable and supplier-managed product catalogues, jointly offering more than 22+M biologicals, chemicals, analytics, plastic ware, laboratory tools and devices being used on daily basis, in all kind of Life Sciences research performed at private companies, universities, and academic hospitals. At present, the platform is used by 26 users. Many of them are members of “Flanders Bio” (https://flanders.bio) and “Flanders Vaccine” (https://flandersvaccine.be) communities. Our mission is to ensure more time and savings for science and innovation by bringing daily operational excellence in procurement while keeping focus on the end-user.

11 to 50 staff

Theratrame

THERAtRAME mission is to therapeutically exploit the common translation mechanisms necessary for the development of human pathologies in order to cure up to now untreatable diseases.

11 to 50 staff

Accretio Management

Accretio Management offers custom-tailored consulting services to start-ups and biotechs in the immunology and oncology fields, to help them make the most of their assets and bring their business to the next level. We offer you tailored competitive intelligence analyses, clinical strategy and business development advice. We team up to guide your decisions, refine your strategies, and give more impact to your science.

1 to 10 staff

Diagam Sa

DiAgam is a private biotechnology company specializing in in-vitro diagnostics for clinical (human) use. Based in Belgium, our company produces Turbidimetric reagents. Its R&D is focused on classical immunological technologies and on the development of innovative technologies based on the use of nanoparticles, such as colloidal Gold in suspended phase. Our reagents, controls and calibrators are liquid, stable and ready to use. They can be adapted to all “open” biochemistry analyzers using suitable vials. Our great production flexibility allows us to offer you all our parameters in different packaging: Kits, Bulk, under the DiAgam label or in OEM. DiAgam SA is ISO 13485: 2016 and ISO 9001 : 2015 certified and all of its diagnostic kits are CE IVD compliant.

11 to 50 staff

Neuvasq Biotechnologies

Neuvasq Biotechnologies is pioneering the development of first-in-class Gpr124- and Reck-targeting Wnt surrogate antibodies, designed to restore the integrity of the blood-retina and blood-brain barriers. This groundbreaking approach holds the potential to transform treatments and improve the lives of patients with vascular retinopathies – diabetic macular edema (DME) and wet age-related macular degeneration (wAMD) – or severe neurological disorders.

1 to 10 staff

Bioxodes

Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.

1 to 10 staff

Progeno

Progeno is a Ghent University spin-off company that aims to empower professional plant and animal breeders by giving them direct access to the state-of-the-art in breeding and selection methods by means of a user-friendly and industry-proven software system. The Progeno software framework is centered around its highly innovative computing engine that allows to integrate all available breeding data, generally including many years of phenotypic trial observations and sometimes vast amounts of molecular marker information, into reliable (genomic) breeding values for all traits of interest. Making the best of your data, Progeno software warrants a more cost-effective breeding program as well as faster genetic progress which in turn are likely to secure a clear edge over your competition.

1 to 10 staff

Dendrogenix

Dendrogenix is a biopharmaceutical company based in Liège (Belgium) dedicated to developing first in class molecules named "Dendrogenins" addressing important medical needs in the field of neurodegenerative diseases, in particular in Hearing Loss indication, and in the field of Oncology.

11 to 50 staff

Exevir

Exevir Bio is a biotech company developing efficacious heavy chain-only antibodies to prevent and treat infectious diseases and make a difference in pandemic preparedness. The technology platform of ExeVir uses humanized camelid heavy chain-only antibody fragments (VHH) fused to a human IgG Fc to create new therapeutic compounds. ExeVir is building a strong pipeline of antibody therapies with an initial focus on COVID-19 and dengue. Compared to conventional monoclonal antibodies, the modular VHH building blocks provide a unique combinatory flexibility. In addition, the design of multi-specific constructs is substantially simplified. VHHs have the potential to access unique and occluded epitopes that are often highly conserved and more difficult, if not impossible, to access for conventional monoclonals. ExeVir has gained extensive experience in the discovery, development and production of mono-specific and multi-specific VHH-Fc constructs, which are very stable, easy to produce and cost-effective. Our lead compound XVR013m is a variant-proof and broad –spectrum long-acting antibody targeting a highly conserved epitope in the S2 subunit of the Spike to protect and treat immunocompromised and elderly. The company is backed up by series A financing and has obtained non-dilutive funding from VLAIO and Horizon. The company was created in 2020 and has its headquarters in Ghent, Belgium.

1 to 10 staff

Molecubes

At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. It is therefore our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows. With more than 100 CUBES installed worldwide, MOLECUBES is a trusted partner by your side. At MOLECUBES we provide three separate benchtop imagers or “CUBES”: The γ-CUBE is our high-resolution, high-sensitivity micro-SPECT scanner using patented collimator design. The X-CUBE is our high-throughput micro-CT scanner allowing sub-minute acquisition at extremely low doses. The β-CUBE is our sub-millimeter, high-sensitivity whole body mouse and rat micro-PET scanner.

11 to 50 staff